sepsis
IL-6 outperformed traditional sepsis biomarkers like C-reactive protein and procalcitonin in the cohorts.
Published on Monday, the work describes a foundational technology being commercialized by startup VedaBio.
The firm laid off all of its employees last month and inked agreements with top executives for part-time consulting work.
Presymptom Health Nabs £200K in Grant Funding for Sepsis and Infectious Disease Test
The firm will use the funding to bring the test to market in the UK, and it plans to soon start a Series A funding round to support expansion into the US market.
CARB-X Awards $3M to AstraDx for Neonatal Sepsis Test Development
The diagnostics startup is developing a testing platform that uses digital imaging and signal processing for pathogen identification and susceptibility determination.
Jan 21, 2025
Jan 16, 2025
Novus Diagnostics Nabs €4.6M in Equity Financing
Oct 22, 2024
Oct 10, 2024
Cytovale Raises $100M in Series D Round
Oct 2, 2024